Efficacy and safety of MCLA-129, an anti-EGFR/c-MET bispecific antibody, in head and neck squamous cell cancer (HNSCC)

被引：0
|
作者：
Bossi, P. [1 ]
Minuti, G. [2 ]
Brana, I. [3 ]
Garcia, V. Moreno [4 ]
Boni, V. [5 ]
Jamme, P. [6 ]
Call, J. A. [7 ]
Yan, C. [8 ]
Barasa, B. [9 ]
Doze, P. [10 ]
Joe, A. K. [11 ]
Laus, G. [11 ]
Daste, A. [12 ]
机构：
[1] IRCCS Humanitas Res Hosp, Med Oncol, Milan, Italy
[2] IRCCS Ist Nazl Tumori Regina Elena IRE, Phase & Precis Med Unit 1, Rome, Italy
[3] Vall Hebron Univ Hosp, Thorac Canc Unit, Barcelona, Spain
[4] Hosp Univ Fdn Jimenez Diaz, START Madrid, FJD Early Phase Clin Trials Unit, Madrid, Spain
[5] Hosp Univ Quironsalud Madrid, Oncol Dept, Pozuelo De Alarcon, Spain
[6] CHU Lille, Haut France, Ctr Hosp Reg Univ Lille, Lille, France
[7] South Texas Accelerated Res Therapeut START, Phase & Trials, San Antonio, TX USA
[8] Merus NV, Biostat, Utrecht, Netherlands
[9] Merus NV, Translat Res, Utrecht, Netherlands
[10] Merus NV, Clin Operat, Utrecht, Netherlands
[11] Merus NV, Clin Dev, Utrecht, Netherlands
[12] CHU Bordeaux, Hop St Andre, Med Oncol, Bordeaux, France
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.10.470
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
362P
引用
收藏
页码：S1610 / S1611
页数：2
相关论文
共 50 条
  • [41] Safety and efficacy of anti-EGFR monoclonal antibody (SCT200) as second-line therapy in advanced esophageal squamous cell cancer.
    Bai, Ming
    Deng, Ting
    Ba, Yi
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [42] Paclitaxel in combination with anti-EGFR therapy as induction chemotherapy for patients unfit for cisplatin with locally advanced head and neck squamous cell carcinoma (LA-HNSCC)
    Marin, J. A.
    Oliva Bernal, M.
    Plana Serrahima, M.
    Ferrer, M.
    Vilarino Quintela, N.
    Vazquez, S.
    Vilajosana, E.
    Lozano, A.
    Nogues, J.
    Mari, A.
    Bermejo, O.
    Mesia Nin, R.
    Taberna Sanz, M.
    ANNALS OF ONCOLOGY, 2018, 29 : 383 - 383
  • [43] Bitter Melon Reduces Head and Neck Squamous Cell Carcinoma Growth by Targeting c-Met Signaling
    Rajamoorthi, Ananthi
    Shrivastava, Shubham
    Steele, Robert
    Nerurkar, Pratibha
    Gonzalez, Juan G.
    Crawford, Susan
    Varvares, Mark
    Ray, Ratna B.
    PLOS ONE, 2013, 8 (10):
  • [44] TLR4 activation leads to anti-EGFR therapy resistance in head and neck squamous cell carcinoma
    Ju, Houyu
    Hu, Zhenrong
    Lu, Yusheng
    Wu, Yunteng
    Zhang, Liming
    Wei, Dongliang
    Guo, Wei
    Xia, Weiya
    Liu, Shuli
    Ren, Guoxin
    Hu, Jingzhou
    AMERICAN JOURNAL OF CANCER RESEARCH, 2020, 10 (02): : 454 - +
  • [45] Uptake of the anti-epidermal growth factor receptor (EGFR) antibody EMD 72000 in tumors of subjects with head and neck squamous cell carcinoma (HNSCC)
    Hoffend, J
    Mohammed, A
    Eisenhut, M
    Bosch, F
    Dietz, A
    Rosen, O
    Kovar, A
    Weber, D
    Tillner, J
    Haberkorn, U
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 205S - 205S
  • [46] Efficacy and safety of anti-EGFR monoclonal antibody (SCT200) as third-line or further treatment in advanced lung squamous cell cancer.
    Dong, Xiaorong
    Wu, Lin
    Huang, Dingzhi
    Cheng, Ying
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [47] Anti-EGFR Targeted Monoclonal Antibody Isotype Influences Antitumor Cellular Immunity in Head and Neck Cancer Patients
    Trivedi, Sumita
    Srivastava, Raghvendra M.
    Concha-Benavente, Fernando
    Ferrone, Soldano
    Garcia-Bates, Tatiana M.
    Li, Jing
    Ferris, Robert L.
    CLINICAL CANCER RESEARCH, 2016, 22 (21) : 5229 - 5237
  • [48] Preclinical efficacy of Sym004, novel anti-EGFR antibody, in esophageal squamous cell carcinoma cell lines
    Fukuoka, Shota
    Kojima, Takashi
    Koga, Yoshikatsu
    Yamauchi, Mayumi
    Komatsuzaki, Rie
    Aoyagi, Kazuhiko
    Sasaki, Hiroki
    Yasunaga, Masahiro
    Matsumura, Yasuhiro
    Kuronita, Toshio
    Doi, Toshihiko
    Ohtsu, Atsushi
    CANCER RESEARCH, 2015, 75
  • [49] Balancing Selectivity and Efficacy of Bispecific Epidermal Growth Factor Receptor (EGFR) X c-MET Antibodies and Antibody-Drug Conjugates
    Sellmann, Carolin
    Doerner, Achim
    Knuehl, Christine
    Rasche, Nicolas
    Sood, Vanita
    Krah, Simon
    Rhiel, Laura
    Messemer, Annika
    Wesolowski, John
    Schuette, Mark
    Becker, Stefan
    Toleikis, Lars
    Kolmar, Harald
    Hock, Bjoern
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2016, 291 (48) : 25106 - 25119
  • [50] EGFR Alterations Influence the Cetuximab Treatment Response and c-MET Tyrosine-Kinase Inhibitor Sensitivity in Experimental Head and Neck Squamous Cell Carcinomas
    Nelhubel, Gyorgyi A.
    Cserepes, Mihaly
    Szabo, Balazs
    Turk, Dora
    Karpati, Adel
    Kenessey, Istvan
    Raso, Erzsebet
    Barbai, Tamas
    Hegedus, Zita
    Laszlo, Viktoria
    Szokol, Balint
    Dobos, Judit
    Orfi, Laszlo
    Tovari, Jozsef
    PATHOLOGY & ONCOLOGY RESEARCH, 2021, 27
12345